Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Study to Assess Symptoms of Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon® (Pancrelipase) With an Alternate Source of Active Pharmaceutical Ingredient

NCT05069597 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05069597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05069597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Study to Assess Symptoms of Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon® (Pancrelipase) With an Alternate Source of Active Pharmaceutical Ingredient
Lead sponsor
AbbVie
Phase
Phase 4
Overall status
Completed
Start date
October 14, 2021
Completion date
August 28, 2023
Enrollment
30 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pancreatitis, cystic fibrosis